Day 2

Publishing and reviewing Workshop

Chair: Dr Lina Schiffer (UK)

Prof Adrian Clark (Editor in Chief, Endocrine Connections & Chair, Bioscientifica)

Prof Karl-Heinz Storbeck (Associate Editor, Journal of Steroid Biochemistry and Molecular Biology)

A guide to academic publishing: encouraging early-career researchers to publish and to know how (including an interactive workshop with hands-on experience)

Islet regeneration: moving towards a novel approach to diabetes

Chair: Dr Anne de Bray (UK)

Dr Ildem Akerman (Birmingham, UK)

Diabetes oral presentations

Chairs: Dr Luba Matchekhina (Russia), Dr Giulia Argentesi (UK)

OR1: A study of type 2 diabetes mellitus with special reference to diabetic kidney disease and its co-relation with neutrophil lymphocyte ratio (Chirag L U, India)

OR2: Does diabetes and poor glycemic control increase the severity and mortality in patients with COVID-19? (Clara Cunha, Portugal)

OR3: Impact of Ambulatory Glucose Profile on HBA1C and Dietary habits amongst patient in Central India (Bharat Saboo, India)

OR4: The relationship between pre-admission insulin usage and mortality of people with diabetes diagnosed with COVID-19 (Emre Saygili, Turkey)

OR5: Sex differences in quality of life and sexual function in type 2 diabetes mellitus: results from the RECOGITO trial (Tiziana Feola, Italy)

OR6: Sex-specific cardioprotection of daily tadalafil in patients with type-2 diabetes. The RECOGITO, randomized, double-blind, placebo-controlled trial (Riccardo Pofi, Italy)

Obesity, Metabolism, and Reproductive Endocrinology oral presentations

Chairs: Dr Jonathan Hazlehurst (UK), Dr Nikolaos Nikolaou (UK)

OR1: Low testosterone is a predictor of hypoxemic respiratory insufficiency and higher mortality rate in SARS-COV-2 hospitalized patients: a cohort study (Walter Vena, Italy)

OR2: Unveiling the therapeutic role of somatostatin and cortistatin in prostate cancer (Jesús Pérez Gómez, Spain)

OR3: Levels of circulating amyloid beta 1-40 are associated with the rate of progression of atherosclerosis in menopause (Elena Armeni, Greece)

OR4: In1-ghrelin as a key element in the pathophysiological association between obesity and prostate cancer (Antonio Montero-Hidalgo, Spain)

OR5: Additive antitumor effect of metformin and simvastatin combination in glioblastoma: evidence for a potential drug repurposing (Antonio Fuentes-Fayos, Spain)

OR6: Unleashing the crosstalk between prostate cancer and obesity: miR-107 as a novel personalized diagnostic and therapeutic tool (Prudencio Sáez-Martínez, Spain)

Progressive academic careers: publishing, industry, and non-research roles

Chairs: Dr Eka Melson (UK), Ms Helen Gregson (Chief Executive Officer, European Society of Endocrinology)

Dr Marta Koch (Editor-in-chief, The Lancet Diabetes & Endocrinology)

Dr Ganesh Manjeri (Senior scientific writer, GlaxoSmithKline)

Dr John Porter (Medical Director, Diurnal Ltd.)

Dr Elizabeth Robertson (Director of Research, Diabetes UK)

Panel Q&A - An overview of progressive academic career options for early-career researchers and endocrinologists

Social networking session: Young Endocrinologists’ Escape Room

In this social activity, delegates will have to follow clues and solve riddles to make their way through Medical History and claim the prize.